- Great Companies Come at Fair Prices
- Options Trading: One Airline Stock May Zoom
- Rally May Take Dow Back to 12,000: Investor
- Hot Options Trading: What It Says for SanDisk
- Stock Picker: My Best Contrarian Play
- Stock Picker: No Place Like Home (Builders)
- Najarian on Options: A Bullish Move on BP
- Stock Picker: Ride the Bat Out Of Hell
- Holland's Bear Advice: Buy the Survivors
- Analyst Picks: Three Resilient Retailers
- Yoshikami: Investing & the Obama Presidency
- Wall of Shame: Fortress Investment's Wes Edens
- Cramer to Geithner: Let FDIC Chair Keep Her Job
- Lightning Round: Boeing, Medtronic, Agrium and More
- Lightning Round OT: Continental, Amylin Pharma and More
- Sell Block: Cramer's Solution for Mortgage-Backed Paper Mess
- Toll Brothers CEO's Housing Outlook
- Making Money Off M&A
- Your First Move For Friday December 5th
- Charts Predict S&P Festive Rally Above 1,000
- BMW's Global Sales Plunge by a Quarter in Nov.
- Pros Say: Job Losses of 425,000; S&P to Fall to 700
- Bleak Jobs Data Forecasts Add to Automakers' Woes
- Euro Stocks Fall Ahead of US Jobs Data
- European Stocks to Open Sharply Lower
- Toshiba to Briefly Halt Chip Output on Weak Demand
- Boeing Mulls Pushing Back Dreamliner Deliveries
- Chief Executive Quits Australian Publisher Fairfax
Text Size 
Gabe Hilmoe is getting an early start on the stock market. He's portfolio manager of the Henry Fund at the University of Iowa, and he's got some strong ideas about equity investments.
The Henry Fund, like many student-run investment vehicles, operates with real money, and the 12 MBA students who run it currently handle about $1.5 million. Hilmoe specializes in the health-care side of the portfolio.
Recommendations:
"Right now, we still like Genentech [DNA
Loading...
()
]," he told CNBC. "We still see more upside, with another Roche bid coming in."
It's not just biotech that he likes; in the medical device field, he's enthusiastic about Stryker [SYK
Loading...
()
].
"It's definitely a growth story," he said. "We see a huge upside in terms of a demographic trend: A lot more people are getting orthopedic surgery, and it's becoming more popular with a younger population as well."
Hilmoe has a pick outside health care as well: Sherwin Williams [SHW
Loading...
()
], a seemingly contrarian play because its best-known product, paint, is so closely tied to housing.
"The idea is that less than 10 percent of their revenues are tied to new residential construction," he explained. "We see a lot of opportunity in emerging markets and...it has room to grow."
________________________
NEW!
________________________
Disclosures:
Disclosure information for Gabe Hilmoe was not immediately available.
Del.icio.us
Digg It
Data is a real-time snapshot *Data is delayed at least 15 minutes